Muscle Relaxants for Abdominal Pain
Primary Recommendation
For abdominal pain due to muscle spasms, antispasmodics with anticholinergic action (such as dicyclomine or hyoscine butylbromide) are the recommended first-line muscle relaxants, as they demonstrate superior efficacy in reducing pain compared to placebo and other agents. 1
Evidence-Based Treatment Approach
First-Line Antispasmodic Agents
Anticholinergic antispasmodics are the most effective class for abdominal pain relief:
- Dicyclomine (dicycloverine) shows the most significant improvement in pain reduction among agents available in North America, though dry mouth may limit tolerability 1
- Hyoscine butylbromide (scopolamine butylbromide) is highly effective with excellent tolerability due to minimal systemic absorption (<1% bioavailability), making it particularly well-suited for abdominal cramping and pain 2
- These agents work by blocking muscarinic receptors on gastrointestinal smooth muscle, directly relaxing spasm at the site of action 2
Alternative Smooth Muscle Relaxants
Direct-acting smooth muscle relaxants provide moderate benefit:
- Mebeverine and alverine citrate act directly on intestinal smooth muscle without anticholinergic effects 1
- Meta-analysis of 26 trials showed overall improvement of 64% with antispasmodics versus 45% with placebo, though mebeverine specifically failed to show significant pain reduction in individual drug analysis 1
- These agents may be preferred when anticholinergic side effects are problematic 1
Important Clinical Distinction
Skeletal muscle relaxants (cyclobenzaprine, tizanidine) are NOT indicated for abdominal pain:
- Cyclobenzaprine is FDA-approved only for acute skeletal muscle spasm associated with musculoskeletal conditions, not visceral smooth muscle spasm 3
- These agents work centrally on somatic motor function, not on gastrointestinal smooth muscle 3, 4
- The sedation from cyclobenzaprine results from off-target histamine H1 receptor antagonism, not therapeutic muscle relaxation 4
Dosing and Duration
Practical prescribing guidelines:
- Dicyclomine: Standard dosing with titration to minimize dry mouth 1
- Hyoscine butylbromide: Available as oral or rectal formulation; exerts local spasmolytic effect with minimal systemic absorption 2
- Duration: Antispasmodics can be used as needed for symptom control, unlike skeletal muscle relaxants which should be limited to 2-3 weeks 3
Adjunctive Considerations
When antispasmodics alone are insufficient:
- Tricyclic antidepressants (low-dose amitriptyline 50mg or trimipramine) are highly effective for chronic abdominal pain through visceral nerve modulation, though constipation limits use in some patients 1
- NSAIDs may be equally or more effective than spasmolytics for biliary or renal colic specifically 5
- Avoid combining antispasmodics with skeletal muscle relaxants, as this adds sedation without addressing visceral smooth muscle spasm 3
Common Pitfalls to Avoid
Critical prescribing errors:
- Do not prescribe cyclobenzaprine or other skeletal muscle relaxants for abdominal pain - they lack efficacy for visceral smooth muscle and cause unnecessary sedation 3, 4
- Avoid anticholinergic antispasmodics if constipation is the predominant symptom, as they may worsen this 1
- Screen for underlying psychiatric conditions (depression, anxiety) that may require specific treatment rather than repeated antispasmodic prescriptions 1
Safety Profile
Tolerability considerations:
- Hyoscine butylbromide demonstrates excellent safety with minimal anticholinergic adverse effects due to poor systemic absorption and inability to cross the blood-brain barrier 2
- Dicyclomine causes more dry mouth but remains generally well-tolerated 1
- Both are substantially safer than skeletal muscle relaxants for this indication, which carry risks of sedation, falls, and central nervous system effects 6